IXHL Incannex Healthcare Inc.
Price Chart
Executive Summary
Incannex Healthcare announced that Alliance Global Partners (AGP) has initiated equity research coverage with a BUY rating and an $18.00 price target. The coverage highlights the company's lead programs IHL-42X (obstructive sleep apnoea) and PSX-001 (generalized anxiety disorder). This is a routine disclosure with no new financial data or operational catalysts.
Actionable Insight
Monitor for clinical trial readouts from the DReAMzz dose optimisation study for IHL-42X and any regulatory updates for PSX-001, which would provide more material catalysts than this research coverage initiation.
Key Facts
- Alliance Global Partners initiated equity research coverage on Incannex Healthcare with a BUY rating
- Price target set at $18.00 per share by analyst James Molloy
- Report dated June 8, 2026, covers IHL-42X and PSX-001 programs
- AGP has received compensation from Incannex for providing investment banking services
Financial Impact
No financial figures reported; analyst price target of $18.00 per share vs. current market cap of $41M
Risk Factors
- Analyst coverage does not guarantee increased investor awareness or liquidity
- AGP has received investment banking compensation from Incannex, creating potential conflict of interest
- Clinical-stage biotech with no approved products carries inherent development and regulatory risk
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-066526 |
| Document: ea029393401ex99-1.htm | 0001213900-26-066526 |
| Document: 0001213900-26-066526-index-headers.html | 0001213900-26-066526 |
| Document: 0001213900-26-066526-index.html | 0001213900-26-066526 |
| Document: 0001213900-26-066526.txt | 0001213900-26-066526 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 10, 2026
10d ago
|
Press Release
| $3.91 $3.73 | ▼ −4.60% | ▼ −8.04% | $3.56 (−8.95%) |
|
Jun 10, 2026
10d ago
|
8-K
| $3.91 $3.73 | ▼ −4.60% | ▼ −8.04% | $3.56 (−8.95%) |
|
Jun 9, 2026
11d ago
|
8-K
| $3.67 $3.67 | · 0.00% | ▼ −2.41% | $3.56 (−3.00%) |
|
May 14, 2026
5w ago
|
Press Release
| $3.88 $3.64 | ▼ −6.19% | ▼ −5.47% | $3.56 (−8.25%) |
|
May 14, 2026
5w ago
|
8-K
| $3.88 $3.64 | ▼ −6.19% | ▼ −5.47% | $3.56 (−8.25%) |
|
May 12, 2026
5w ago
|
8-K
| $3.90 $3.79 | ▼ −2.82% | ▼ −2.90% | $3.56 (−8.72%) |
|
Apr 22, 2026
8w ago
|
8-K
| $4.09 $3.95 | ▼ −3.42% | ▼ −3.48% | $3.56 (−12.96%) |
|
Mar 27, 2026
12w ago
|
Press Release
| $3.24 $2.56 | ▼ −20.99% | ▼ −24.85% | $3.56 (+9.88%) |
|
Mar 25, 2026
12w ago
|
Press Release
| $3.22 $2.96 | ▼ −8.07% | ▼ −7.83% | $3.56 (+10.56%) |
|
Mar 18, 2026
13w ago
|
8-K
| $3.09 $3.22 | ▲ +4.21% | ▲ +4.92% | $3.56 (+15.21%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access